Skip to main content

Centuri Holdings Inc

For the period ended Dec 29, 2024. Filed Feb 26, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 26, 2025

CTRI$22.560.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Centuri Holdings, Inc. Consolidated Statements of Operations

Consolidated Statements of Operations

(In thousands, except per-share information)

Fiscal Year Ended
December 29,2024December 31,2023January 1,2023
Revenue$2,530,394$2,782,845$2,625,669
Revenue, related party - parent106,835116,431134,658
Total revenue, net2,637,2292,899,2762,760,327
Cost of revenue (including depreciation)2,319,7442,520,4202,428,722
Cost of revenue, related party - parent (including depreciation)96,813105,414116,993
Total cost of revenue2,416,5572,625,8342,545,715
Gross profit220,672273,442214,612
Selling, general and administrative expenses107,247110,344109,197
Amortization of intangible assets26,64226,67029,759
Goodwill impairment—213,992177,086
Operating income (loss)86,783(77,564)(101,430)
Interest expense, net90,51597,47661,371
Other (income) expense, net(376)(64)887
Loss before income taxes(3,356)(174,976)(163,688)
Income tax expense3,4669,5301,298
Net loss(6,822)(184,506)(164,986)
Net (loss) income attributable to noncontrolling interests(98)1,6703,159
Net loss attributable to common stock$(6,724)$(186,176)$(168,145)
Loss per share attributable to common stock:
Basic$(0.08)$(2.60)$(2.35)
Diluted$(0.08)$(2.60)$(2.35)
Shares used in computing earnings per share:
Weighted average basic shares outstanding83,28671,66671,666
Weighted average diluted shares outstanding83,28671,66671,666
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.